Article: Par collaborates with Spectrum.(Par Pharmaceutical Inc., Spectrum Pharmaceutical Inc.)(Brief Article)

New York State-based Par Pharmaceutical says that it has entered into a collaborative agreement with fellow US firm Spectrum Pharmaceuticals to develop and market generic drugs, including copy versions of injectable and ophthalmic medicines. Spectrum, located in Irvine, California, is a specialty pharmaceutical company that develops both proprietary and generic drugs.

"Our collaboration with Spectrum will expand the therapeutic scope, as well as the size of Par's generic product pipeline," said Scott Tarriff, chief executive of the latter. "This agreement provides Par access to generic injectable and ophthalmic drugs, and adds a highly-valued, first-to-file ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!